Find a Tender
complete
Official procurement procedure
NHS National Framework for the supply of Ustekinumab - 1 September 2024
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for the supply of Ustekinumab - 1 September 2024". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
6.1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published12 Sept 2024, 16:51 BST | Last source update12 Sept 2024, 16:51 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-046cc5 | ||
What is being bought
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024<br/><br/>Offer reference number: CM/TNS/24/5711<br/><br/>CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
- tender value changed
12 Sept 2024, 16:51 BST - Status changed to complete
12 Sept 2024, 16:51 BST - Official notice release published
12 Sept 2024, 16:51 BST - Submission deadline changed to published date
12 Sept 2024, 16:51 BST - Published value updated to £579,000,000
31 May 2024, 16:05 BST - Status changed to active
31 May 2024, 16:05 BST - Official notice release published
31 May 2024, 16:05 BST - Submission deadline changed to 1 Jul 2024, 13:00 BST
31 May 2024, 16:05 BST - Buyer information updated
31 May 2024, 16:05 BST
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & SouthcancelledPublished valueNot publishedCM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAEcancelledPublished valueNot publishedCM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
12 Sept 2024, 16:51 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1 - Contract active
Signed 13 Aug 2024, 00:00 BST · £1
Commercial outcome and competition
Awards Amgen Ltd Not published · Not published · active Celltrion Healthcare United Kingdom Limited Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active Celltrion Healthcare United Kingdom Limited Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active |
Contracts NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - London & South of England. £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active NHS Framework for the supply of Ustekinumab - North of England and Midlands & East £1 · signed 13 Aug 2024, 00:00 BST · active |
Bid statistics bids: 6 (lot 1) bids: 6 (lot 1) bids: 6 (lot 1) bids: 6 (lot 1) bids: 6 (lot 1) bids: 6 (lot 1) electronicBids: 6 (lot 1) electronicBids: 6 (lot 1) electronicBids: 6 (lot 1) electronicBids: 6 (lot 1) electronicBids: 6 (lot 1) electronicBids: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromEU: 6 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 1 (lot 1) smeBids: 1 (lot 1) smeBids: 1 (lot 1) smeBids: 1 (lot 1) smeBids: 1 (lot 1) smeBids: 1 (lot 1) bids: 6 (lot 2) bids: 6 (lot 2) bids: 6 (lot 2) bids: 6 (lot 2) bids: 6 (lot 2) bids: 6 (lot 2) electronicBids: 6 (lot 2) electronicBids: 6 (lot 2) electronicBids: 6 (lot 2) electronicBids: 6 (lot 2) electronicBids: 6 (lot 2) electronicBids: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromEU: 6 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-107961Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published